Atherosclerotic Cardiovascular Disease (ASCVD) Risk Management, Part 1
From July 2016, Creme de la ThyroidDiscuss an evidence based approch to atheroscelotic cardiovascular disase risk managment. •
15min 38Spencer Blackman, MD and Rob Orman, MD
Atherosclerotic Cardiovascular Disease (ASCVD) Risk Management, Part 2
From July 2016, Creme de la ThyroidPart 2 of our conversation with Spencer Blackman on his group’s approach to ASCVD risk management including: specific cases, the role of niacin, and shared decision making. •
9min 32Spencer Blackman, MD and Rob Orman, MD
Paper Chase 2: Long-Term Primary Prevention Benefits of Statin Therapy
From June 2016, C Diff Shows No Mercy!Statin treatment for five years was associated with a legacy benefit with improved survival and a substantial reduction in cardiovascular disease outcomes over a 20-year period. •
5min 5Andrew Buelt, DO and Joe Weatherly, DO